GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

It was a figure I saw. As another poster observed, such
things are not straightforward in estimation, since a good
deal of the business is private, and the boundaries of the
field are ill-defined. My wife has a saying, never argue
religion with a Baptist. Perhaps you saw the short item
in Nature Biotechnology a while back addressing the religious
dimension of biotech fanaticism.

Just so you and rustyboy understand the POINT of my remark,
it was that the future of biotech is bright indeed from every
point of view except that of the OWNERS. They are certainly
not the only stakeholders, but they ARE stakeholders.

In more ways than one. Perhaps, as has been suggested in
the media, the industry will witness an aggregate profit by
the end of this decade. Perhaps GTCB will survive, if only
as the result of our acceptance of a two dollar offer. But
you are whistling past the graveyard with your God is in His
Heaven and all is right with the world attitude, and this
essay sets forth some of the reasons why:

http://www.bio.org/tax/sec382/HR2968White_Paper.pdf

Now I'm hauling my fatuous ass back to Yahoo where pointless
rhetoric is properly appreciated. Enjoy your profits, should
they materialize.